Our findings demonstrated that CD8-predominant AITL is a distinct immune pattern of AITL characterized by anti-tumor immunity impairment and an immunosuppressive microenvironment. This evidence concerns the gene CD8A and angioimmunoblastic T-cell lymphoma.